Longitudinal analysis of cardiovascular parameters after gastric bypass surgery

Surgery for Obesity and Related Diseases

Volumn 8, Issue 6, 2012, Pages 703-709

  Dallal, Ramsey M ^a   Hatalski, Amanda ^a   Trang, Alfred ^a   Chernoff, Arthur ^a  

^a EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Bariatric surgery; C reactive protein; Diabetes; Gastric bypass; Hyperlipidemia; Hypertension; Longitudinal analysis; Metabolic syndrome; Mixed models; Obesity; Weight loss surgery

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAUCASIAN; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISPANIC; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NEGRO; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOGLYCEMIA; LIPIDS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE CARE; SEX FACTORS; YOUNG ADULT;

EID: 84869141710     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2011.09.020     Document Type: Article

References (26)

1. A. Torquati, K. Wright, W. Melvin, W. Richards Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity J Am Coll Surg 204 2007 776 782
2. H.J. Sugerman, L.G. Wolfe, D.A. Sica, J.N. Clore Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss Ann Surg 237 2003 751 758
3. N.T. Nguyen, E. Varela, A. Sabio, C.L. Tran, M. Stamos, S.E. Wilson Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass J Am Coll Surg 203 2006 24 29
4. S.M. Zagorski, N.N. Papa, M.H. Chung The effect of weight loss after gastric bypass on C-reactive protein levels Surg Obes Relat Dis 1 2005 81 85
5. S.B. Chen, Y.C. Lee, K.H. Ser Serum C-reactive protein and white blood cell count in morbidly obese surgical patients Obes Surg 19 2009 461 466
6. C. Holdstock, L. Lind, B.E. Engstrom CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects Int J Obes 29 2005 1275 1280
7. J.A. Batsis, A. Romero-Corral, M.L. Collazo-Clavell Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery Obesity 15 2007 772 784
8. J.D. Fernstrom, A.P. Courcoulas, P.R. Houck, M.H. Fernstrom Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery Arch Surg 141 2006 276 283
9. M.W. Hinojosa, J.E. Varela, B.R. Smith, F. Che, N.T. Nguyen Resolution of systemic hypertension after laparoscopic gastric bypass J Gastrointest Surg 13 2009 793 797
10. T.D. Adams, R.E. Gress, S.C. Smith Long-term mortality after gastric bypass surgery N Engl J Med 357 2007 753 761
11. K.M. Flegal, M.D. Carroll, C.L. Ogden, L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
12. R.M. Dallal, B.B. Quebbemann, L.H. Hunt, L.E. Braitman Analysis of weight loss after bariatric surgery using mixed-effects linear modeling Obes Surg 19 2009 732 737
13. P.R. Schauer, B. Burguera, S. Ikramuddin Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus Ann Surg 238 2003 467 485
14. A.Z. Fernandez Jr, E.J. DeMaria, D.S. Tichansky Experience with over 3,000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and resultant mortality Surg Endosc 18 2004 193 197
15. W.J. Pories, K.G. MacDonald Jr., E.J. Morgan Surgical treatment of obesity and its effect on diabetes: 10-y follow-up Am J Clin Nutr 55 1992 582S 585S
16. M.W. Hinojosa, J.E. Varela, B.R. Smith, F. Che, N.T. Nguyen Resolution of systemic hypertension after laparoscopic gastric bypass J Gastrointest Surg 13 2009 793 797
17. A. Patriti, E. Facchiano, A. Sanna, N. Gullà, A. Donini The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery Obes Surg 14 2004 840 848
18. T.L. Kindel, S.M. Yoder, R.J. Seeley, D.A. D'Alessio, P. Tso Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism J Gastrointest Surg 13 2009 1762 1772
19. R. Morínigo, A.M. Lacy, R. Casamitjana, S. Delgado, R. Gomis, J. Vidal GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects Obes Surg 16 2006 1594 1601
20. J. Vidal, J. Nicolau, F. Romero Long-term effects of Roux-en-Y gastric bypass surgery on plasma GLP-1 and islet function in morbidly obese subjects J Clin Endocrinol Metab 94 2009 884 891
21. R.S. Rao, S. Kini GIP and bariatric surgery Obes Surg 21 2011 244 252
22. M.R. Ali, M.B. Maguire, B.M. Wolfe Assessment of obesity-related comorbidities: a novel scheme for evaluating bariatric surgical patients J Am Coll Surg 202 2006 70 77
23. H.C. Gerstein, M.E. Miller, R.P. Byington Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
24. W.C. Cushman, G.W. Evans, R.P. Byington Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
25. W. Bestermann, M.C. Houston, J. Basile Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome Am J Med Sci 329 2005 292 305
26. X.Q. Zhao, R.A. Krasuski, J. Baer Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS) Am J Cardiol 104 2009 1457 1464